184 related articles for article (PubMed ID: 32031658)
1. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Suárez-Díaz S; Mozo L; Benavente L; Caminal-Montero L; Suárez A
Rheumatology (Oxford); 2020 Jul; 59(7):1752-1764. PubMed ID: 32031658
[TBL] [Abstract][Full Text] [Related]
2. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
[TBL] [Abstract][Full Text] [Related]
3. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ
PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
Ammirati E; Bozzolo EP; Contri R; Baragetti A; Palini AG; Cianflone D; Banfi M; Uboldi P; Bottoni G; Scotti I; Pirillo A; Grigore L; Garlaschelli K; Monaco C; Catapano AL; Sabbadini MG; Manfredi AA; Norata GD
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):751-9. PubMed ID: 24787906
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
[TBL] [Abstract][Full Text] [Related]
6. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
[TBL] [Abstract][Full Text] [Related]
7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
8. Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suarez A
J Leukoc Biol; 2016 Mar; 99(3):405-12. PubMed ID: 26232454
[TBL] [Abstract][Full Text] [Related]
9. The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.
Bortoluzzi A; Chighizola CB; Fredi M; Raschi E; Bodio C; Privitera D; Gonelli A; Silvagni E; Govoni M; Cavazzana I; Airò P; Meroni PL; Tincani A; Franceschini F; Piantoni S; Casciano F
Front Immunol; 2020; 11():572876. PubMed ID: 33193356
[TBL] [Abstract][Full Text] [Related]
10. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus.
Rahman S; Sagar D; Hanna RN; Lightfoot YL; Mistry P; Smith CK; Manna Z; Hasni S; Siegel RM; Sanjuan MA; Kolbeck R; Kaplan MJ; Casey KA
Ann Rheum Dis; 2019 Jul; 78(7):957-966. PubMed ID: 31040119
[TBL] [Abstract][Full Text] [Related]
11. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suárez A
Int J Cardiol; 2017 Jun; 236():138-144. PubMed ID: 28279502
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.
Rodríguez M; Guardiola M; Oliva I; Carles Vallvé J; Ferré R; Masana L; Parra S; Ribalta J; Castro A
Int J Rheum Dis; 2019 Mar; 22(3):480-487. PubMed ID: 30450745
[TBL] [Abstract][Full Text] [Related]
13. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.
Ajeganova S; Hafström I; Frostegård J
Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33547230
[TBL] [Abstract][Full Text] [Related]
14. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
[TBL] [Abstract][Full Text] [Related]
15. Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density.
Rodríguez-Carrio J; Martínez-Zapico A; Cabezas-Rodríguez I; Benavente L; Pérez-Álvarez ÁI; López P; Cannata-Andía JB; Naves-Díaz M; Suárez A
Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):135-143. PubMed ID: 30559042
[TBL] [Abstract][Full Text] [Related]
16. Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.
Carbone F; Dallegri F; Montecucco F; Poggi A; Nobili FM; Cacciapaglia F; Afeltra A; Moccetti T; Colombo BM
Eur J Clin Invest; 2019 May; 49(5):e13089. PubMed ID: 30767212
[TBL] [Abstract][Full Text] [Related]
17. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
Garcia-Garcia P; Castejon R; Tutor-Ureta P; Silvestre RA; Mellor-Pita S; Jimenez-Ortiz C; Yebra-Bango M
Clin Rheumatol; 2017 Dec; 36(12):2709-2717. PubMed ID: 28914371
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
Burbano C; Vasquez G; Rojas M
Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
[TBL] [Abstract][Full Text] [Related]
19. Association of monocyte to high-density lipoprotein cholesterol ratio with carotid artery intima-media thickness in patients with systemic lupus erythematosus.
Wang Q; Meng Y; Cao W; Du W; Liu Y; Yan Y; Luo L; Ma X
Biomark Med; 2018 Apr; 12(4):359-364. PubMed ID: 29569475
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients.
Wu Z; Zhang S; Zhao L; Fei Y; Wang L; Li J; Wen X; Zeng X; Zhang F; Li Y
Clin Rheumatol; 2017 Oct; 36(10):2281-2287. PubMed ID: 28821990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
